These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18847422)

  • 1. [Peritoneal dialysis solutions].
    Montenegro J
    Nefrologia; 2008; 28 Suppl 5():59-65. PubMed ID: 18847422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume control in peritoneal dialysis patients: role of new dialysis solutions.
    Lameire N
    Blood Purif; 2004; 22(1):44-54. PubMed ID: 14732811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study.
    Pajek J; Kveder R; Bren A; Gucek A; Bucar M; Skoberne A; Waniewski J; Lindholm B
    Nephrol Dial Transplant; 2009 May; 24(5):1617-25. PubMed ID: 19066345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of bicarbonate peritoneal dialysis solutions on cardiac structural and functional alterations.
    Theodoridis M; Tziakas D; Passadakis P; Kantartzi K; Roumeliotis A; Thodis E; Vargemezis V
    Nephrol Dial Transplant; 2011 Dec; 26(12):4061-7. PubMed ID: 21543656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
    Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
    Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
    Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome?
    Grzegorzewska AE
    Pol Arch Med Wewn; 2009 Apr; 119(4):242-7. PubMed ID: 19413184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicarbonate solutions: update.
    Diaz-Buxo JA
    Adv Perit Dial; 2005; 21():115-9. PubMed ID: 16686299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.
    Rippe B; Simonsen O; Heimbürger O; Christensson A; Haraldsson B; Stelin G; Weiss L; Nielsen FD; Bro S; Friedberg M; Wieslander A
    Kidney Int; 2001 Jan; 59(1):348-57. PubMed ID: 11135090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis solutions low in glucose degradation products: clinical experience and outcomes.
    Diaz-Buxo JA
    Adv Perit Dial; 2007; 23():132-4. PubMed ID: 17886619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.
    Williams JD; Topley N; Craig KJ; Mackenzie RK; Pischetsrieder M; Lage C; Passlick-Deetjen J;
    Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study.
    le Poole CY; van Ittersum FJ; Weijmer MC; Valentijn RM; ter Wee PM
    Adv Perit Dial; 2004; 20():170-6. PubMed ID: 15384821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
    Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
    Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution.
    MacGinley R; Cooney K; Alexander G; Cohen S; Goldsmith DJ
    Am J Kidney Dis; 2002 Nov; 40(5):1030-5. PubMed ID: 12407649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.